After nearly 15 years' research, scientists at the UdeM-affiliated CHU Sainte-Justine have developed a compound that has shown remarkable potential in preventing prematurity in mice.
Between 1632 and 1760, records show that 734 Indigenous children were enslaved in France's North American colony, historian Dominique Deslandres reveals in two recent studies.
Developed at UdeM, the molecule could soon be approved in Europe to treat blood cancers in patients without a compatible donor – a major step towards commercialization.
